Cencora
Cencora, formerly known as the Clinical Research Division of AmerisourceBergen, is a prominent player in the global pharmaceutical services industry. Headquartered in the United States, Cencora operates extensively across North America, Europe, and Asia, providing comprehensive solutions that span clinical trial management, supply chain logistics, and commercialisation services. Founded in 2022, the company has quickly established itself as a leader in the sector, leveraging its extensive expertise to support biopharmaceutical companies in bringing innovative therapies to market. Cencora's core offerings include tailored clinical trial services and advanced supply chain solutions, distinguished by their commitment to quality and efficiency. With a focus on enhancing patient access to critical medications, Cencora has achieved notable milestones, positioning itself as a trusted partner in the healthcare landscape. Its dedication to innovation and excellence continues to drive its success in an ever-evolving market.
DitchCarbon Score
How does Cencora's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cencora's score of 60 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cencora's reported carbon emissions
In 2024, Cencora reported total carbon emissions of approximately 40,504,084 kg CO2e, with significant contributions from Scope 1, Scope 2, and Scope 3 emissions. Specifically, Scope 1 emissions were about 135,087,000 kg CO2e, while Scope 2 emissions totalled approximately 79,063,000 kg CO2e (market-based). Scope 3 emissions were notably high at around 40,504,084,000 kg CO2e, which includes downstream transportation and distribution emissions of about 254,545,000 kg CO2e. In 2023, Cencora's total emissions were approximately 67,257,000 kg CO2e, with Scope 1 emissions at about 35,664,000 kg CO2e and Scope 2 emissions at approximately 77,400 kg CO2e (market-based). The Scope 3 emissions for that year were around 30,838,000 kg CO2e. Cencora has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 54.6% by FY2032, using FY2019 as the baseline year. This target is aligned with the Science Based Targets initiative (SBTi) and reflects a commitment to sustainable practices within the healthcare sector. Additionally, Cencora plans for 82% of its suppliers by spend to have science-based targets by FY2027, further enhancing its sustainability efforts. The emissions data and targets are not cascaded from any parent organization, indicating that Cencora is independently managing its carbon footprint and climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 98,742,000 | 000,000,000 | 00,000,000 | 000,000,000 |
| Scope 2 | 100,593,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 19,881,916,000 | 00,000,000,000 | 00,000,000 | 00,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cencora is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
